Page last updated: 2024-11-04

sulfamethoxazole and Hemolytic-Uremic Syndrome

sulfamethoxazole has been researched along with Hemolytic-Uremic Syndrome in 1 studies

Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.

Hemolytic-Uremic Syndrome: A syndrome that is associated with microvascular diseases of the KIDNEY, such as RENAL CORTICAL NECROSIS. It is characterized by hemolytic anemia (ANEMIA, HEMOLYTIC); THROMBOCYTOPENIA; and ACUTE RENAL FAILURE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Thisyakorn, U1

Other Studies

1 other study available for sulfamethoxazole and Hemolytic-Uremic Syndrome

ArticleYear
Shigellemia and hemolytic-uremic syndrome: a case report.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 1987, Volume: 70, Issue:8

    Topics: Child, Preschool; Drug Combinations; Drug Resistance, Microbial; Dysentery, Bacillary; Female; Hemol

1987